EGFR is an overexpressed and validated target in various cancers such as colorectal, gynecological and urological cancers, squamous cell carcinomas (SSC) of the head and neck, non-small cell lung cancer, renal and breast neoplasms and gliomas [7]. Here, EGFR is linked to central nervous system cancer.